Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 3/20 | 0.57 |
| ▸ | GPR3 | P46089 | 1/20 | 0.52 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18267540 | 0.91 | ELANE (0.52) | ELANEMAOAGPR3KDM4EALDH1A1 | |
| SCHEMBL12796758 | 0.89 | CHEK1 (0.59) | ELANEMAOAGPR3CHEK1MEN1 | |
| SCHEMBL20389945 | 0.87 | MAOA (0.59) | ELANEMAOACHEK1MEN1KMT2A | |
| SCHEMBL13421899 | 0.87 | GPR3 (0.64) | ELANEMAOAGPR3CHEK1MEN1 | |
| SCHEMBL472539 | 0.82 | GPR3 (0.75) | MAOAGPR3CHEK1MEN1KMT2A | |
| SCHEMBL29368441 | 0.82 | GPR3 (0.75) | MAOAGPR3CHEK1MEN1KMT2A | |
| SCHEMBL31472931 | 0.82 | GPR3 (0.75) | MAOAGPR3CHEK1MEN1KMT2A | |
| SCHEMBL22727240 | 0.82 | ELANE (0.58) | ELANEMAOAGPR3CHEK1MEN1 | |
| SCHEMBL1610760 | 0.80 | GPR3 (0.44) | ELANEMAOAGPR3KDM4EALDH1A1 | |
| SCHEMBL17322540 | 0.79 | GPR3 (0.64) | ELANEMAOAGPR3CHEK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11552254-B2 | Thermally activated delayed fluorescent molecular material, a synthesizing method therefor, and an electroluminescent device | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2023-01-10 | — | — | US | disclosed |
| US-20200381632-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENT MOLECULAR MATERIAL, A SYNTHESIZING METHOD THEREFOR, AND AN ELECTROLUMINESCENT DEVICE | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-12-03 | — | — | US | disclosed |
| WO-2020237991-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENT MOLECULAR MATERIAL, SYNTHESIS METHOD THEREFOR, AND ELECTROLUMINESCENT DEVICE | 武汉华星光电半导体显示技术有限公司 | 2020-12-03 | — | — | WO | disclosed |
| US-20200339546-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENT MOLECULAR MATERIAL, METHOD FOR SYNTHESIZING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-10-29 | — | — | US | disclosed |
| US-10175557-B2 | Optical wavelength conversion element containing ionic liquid, and article equipped with said optical wavelength conversion element | NIPPON KAYAKU KABUSHIKIKAISHA (JP) | 2019-01-08 | — | — | US | disclosed |
| US-20170084758-A1 | Optical Wavelength Conversion Element Containing Ionic Liquid, And Article Equipped With Said Optical Wavelength Conversion Element | NIPPON KAYAKU KABUSHIKIKAISHA (JP) | 2017-03-23 | — | — | US | disclosed |
| US-4103015-A | TRICYCLIC THIOXANTHONE-10,10-DIOXIDES | BURROUGHS WELLCOME CO. (US) | 1978-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11552254-B2 | Thermally activated delayed fluorescent molecular material, a synthesizing method therefor, and an electroluminescent device | FARSB, WEE1, WASF2 | ELANE 4814/4885MAOA 2497/4885GPR3 4356/4885 |
| US-20200339546-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENT MOLECULAR MATERIAL, METHOD FOR SYNTHESIZING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE | PNMT, NONO, INMT | ELANE 3998/4885MAOA 742/4885GPR3 3791/4885 |
| US-20200381632-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENT MOLECULAR MATERIAL, A SYNTHESIZING METHOD THEREFOR, AND AN ELECTROLUMINESCENT DEVICE | FARSB, WEE1, WASF2 | ELANE 4814/4885MAOA 2497/4885GPR3 4356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.